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Abstract
AIM
To identify a preoperative blood marker predictive of 
alveolar echinococcosis (AE) recurrence after hepa-
tectomy.
METHODS
All consecutive patients who underwent operation for 
liver AE at the Lausanne University Hospital (CHUV) 
between January 1992 and December 2015 were 
included in this retrospective study. Preoperative 
laboratory values of leukocytes, mean corpuscular 
volume (MCV), red blood cell distribution width 
(RDW), thrombocytes, C-reactive protein (CRP) and 
albumin were collected and analyzed. Univariate and 
multivariate Cox regression analyses were performed 
to determine the risk factors for AE recurrence after 
liver resection. A receiver operating characteristic 
(ROC) curve was used to define the best discrimination 
threshold of the blood marker. Moreover, recurrence-
free survival curves were calculated using the Kaplan-
Meier method.
RESULTS
The cohort included 68 adult patients (37 females) 
with median age of 61 years [interquartile range 
(IQR): 46-71]. Eight of the patients (12%) presented a 
recurrence over a median follow-up time of 76 mo (IQR: 
34-128). Median time to recurrence was 10 mo (IQR: 
6-11). Median preoperative leukocyte, MCV, RDW, 
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thrombocyte and CRP levels were similar between 
recurrent and non-recurrent cases. Median preoperative 
albumin level was 43 g/L (IQR: 41-45) for non-
recurrent cases and 36 g/L (IQR: 33-42) for recurrent 
cases (P  = 0.005). The area under the ROC curve 
for preoperative albumin level to predict recurrence 
was 0.840 (95%CI: 0.642-1, P  = 0.002). The cut-
off albumin level value was 37.5 g/L for sensitivity 
of 94.5% and specificity of 75%. In multivariate 
analysis, preoperative albumin and surgical resection 
margins were independent predictors of AE recurrence 
(HR = 0.099, P  = 0.007 and HR = 0.182, P  = 0.045 
respectively).
CONCLUSION
Low preoperative albumin level was associated with AE 
recurrence in the present cohort. Thus, preoperative 
albumin may be a useful biomarker to guide follow-up.
Key words: Liver surgery; Alveolar echinococcosis; 
Albumin; Predictive marker; Recurrence
© The Author(s) 2017. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: This study assessed different blood markers 
as potential preoperative predictors of recurrence of 
alveolar echinococcosis (AE) after liver resection. A 
preoperative serum albumin level of < 37.5 g/L was 
found to be associated with AE recurrence after liver 
resection. Preoperative albumin level is easy to obtain 
and could represent a useful tool to guide postoperative 
follow-up after hepatectomy for AE.
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INTRODUCTION
Liver alveolar echinococcosis (AE) is a rare parasitic 
infection caused by Echinococcus multilocularis[1]. 
As this infection behaves like a malignant tumor, 
surgical resection is the treatment of choice when total 
ablation of the parasitic lesions can be achieved[2]. 
Even in cases of surgical liver resection with negative 
histological margins (R0), 2%-5% of the patients will 
present with recurrence during lifetime[3]. 
As the global incidence of AE is low and AE is 
endemic only in certain parts of the world[4], no specific 
risk factors for recurrence after hepatectomy have 
been described yet. Furthermore, no preoperative 
blood markers predictive of AE recurrence have been 
reported. 
Predictive blood markers should be easy to measure 
and interpret for clinical use[5,6]. Typical markers of 
inflammation, including leukocytes, thrombocytes and 
C-reactive protein (CRP), represent such candidate 
blood markers. Mean corpuscular volume (MCV) and 
red blood cell distribution width (RDW) are included as 
well, based upon findings from several recent studies 
that have shown their levels to be correlated with 
liver inflammation[7,8]. Serum albumin has also been 
assessed following new data from liver surgery that 
have indicated a correlation with inflammation, peri-
operative stress and postoperative complications[9-11]. 
The aim of the present study was to assess poten-
tial preoperative biological blood markers to predict 
recurrence in patients operated for liver AE.
MATERIALS AND METHODS
Patients and data collection
Medical records of all consecutive patients with liver 
AE who were operated on in the Department of 
Visceral Surgery, University Hospital CHUV, Lausanne, 
Switzerland, between January 1992 and December 
2015, were retrospectively reviewed for data on 
demographics, peri-operative details and postopera-
tive outcomes. Recurrent cases were chosen for the 
analysis. The study was recorded in the Research 
Registry (UIN: researchregistry1033) and approved 
by the local ethics committee. Informed consent was 
obtained from each participant included in the study. 
The study protocol conforms to the provisions of the 
Declaration of Helsinki.
Diagnostic methods
All patients underwent thoraco-abdominal computed 
tomography (CT) scan to assess hepatic involvement 
and presence of extrahepatic lesions. In case of CT-
suspected AE, serology using western blotting and 
enzyme-linked immunosorbent assay, and liver 
magnetic resonance imaging (MRI) were performed. 
In case of preoperative jaundice, percutaneous or 
endoscopic biliary drainage was placed. If the esti-
mated future remnant liver was < 30% of total liver 
volume, preoperative portal vein embolization was 
systematically performed. AE lesions were staged 
according to the PNM classification of the World 
Health Organization (WHO)[12]. All patients with liver 
AE or high suspicion of AE, independent of the lesion 
size, were candidates for hepatectomy. Anatomical 
resections were performed. Contra-indications to 
surgery were Child-Pugh C cirrhosis, comorbidities 
precluding general anesthesia, or estimated future 
remnant liver < 30% of total liver volume after 
portal vein embolization. No surgical strategy change 
occurred during the study period.
Peri-operative outcomes
Major hepatectomy was defined as liver resection of ≥ 
3 Couinaud’s segments, whereas minor hepatectomy 
consisted of resection of 1 or 2 segments. Postoperative 
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complications were graded according to the Clavien 
classification[13]. R0 resection was defined as negative 
histological margins (> 1 mm) and R1 resection as 
positive histological margins. During the study period, 
3 senior surgeons specialized in AE performed all liver 
resections.
Blood tests
Preoperative laboratory values of leukocytes, MCV, RDW, 
thrombocytes, CRP and albumin were determined at 
the time of hospital admission. These blood tests were 
performed the day before the operation for all patients.
Follow-up and recurrence
Benzimidazole was given for 2 years after R0 resections 
and lifelong after R1 resections, according to WHO 
guidelines[14]. Patients were seen at the outpatient 
clinic 1 mo postoperatively. They were also seen twice 
by the surgeon in a clinical encounter at 6 mo and 1 
year after the operation. Moreover, patients had regular 
(monthly) appointments with the infectiologist for 
follow-up of the albendazole blood levels and standard 
serologies. In case of clinical recurrence suspicion 
or positive serologies, complementary imaging (CT/
MRI) was performed. Recurrence was defined as the 
appearance of new intrahepatic or extrahepatic disease 
after R0 resection or intrahepatic disease progression 
after R1 resection.
Statistical analysis
For continuous variables, a Mann-Whitney U test or 
Student’s t-test was used depending on the normality 
of the distribution and homogeneity of the variances. 
Survival curves were calculated using the Kaplan-Meier 
method, and the log-rank test was used to compare 
survivals. To assess the discriminative power of the 
marker, a receiver operating characteristic (ROC) curve 
analysis was performed. P < 0.05 was considered 
significant. Univariate and multivariate analyses were 
performed using Cox regressions. Only those factors 
with P < 0.1 (10%) on univariate analysis were included 
in the multivariate analysis. All statistical analyses were 
performed using GraphPad Prism 5.0© for Mac OS X 
and SPSS 19.0© for Mac OS X. The statistical methods 
of this study were reviewed by Dr. Jocelyn Bellier from 
the University Hospital CHUV, Lausanne, Switzerland.
RESULTS
Patient characteristics and peri-operative outcomes
During the study period, a total of 68 patients (31 
men, 37 women) were diagnosed with AE and under-
went liver resection. Between 1992 and 2003, major 
hepatectomies were performed in 12 patients and 
minor hepatectomies in 10 patients. Between 2004 
and 2015, 27 patients underwent major hepatectomies 
and 19 patients minor hepatectomies. The median age 
was 61 years [interquartile range (IQR) 46-71]. Eight 
patients also had additional extrahepatic lesions. Minor 
hepatectomy was performed in 29 patients (43%) 
and major hepatectomy in 39 (57%). Postoperative 
complications occurred in 23 patients (34%). Minor 
(grade Ⅰ-Ⅱ) and major (grade Ⅲ-Ⅳ) complications 
were observed in 16 (24%) and 7 patients (10%) 
respectively. One death (grade Ⅴ) occurred during the 
postoperative period and was due to septic shock. The 
90-d mortality was 1/68 (1.5%). The median overall 
survival (OS) was 69 mo for the entire cohort (IQR: 
30-111). 
Recurrent cases
Eight of the total 68 patients presented with recu-
rrence over a median follow-up of 76 mo (IQR: 34-128). 
Median time to recurrence was 10 mo (IQR: 6-11). 
There were no statistically significant differences be-
tween patients with and without recurrence in terms 
of demographics and preoperative characteristics. For 
cases with recurrence the median OS was 81 mo (IQR: 
34-108), compared to 69 mo (IQR: 30-113, P = 0.932) 
for cases without recurrence. Regarding the treatments 
of the 8 patients with recurrence, 4 underwent a 
repeat hepatectomy, 1 a palliative biliodigestive 
bypass, 1 a thoracic wedge resection, and 2 pursued 
long-term medical treatment with albendazole.
Preoperative blood tests 
For recurrent and non-recurrent cases, the median 
laboratory values were: leukocytes: 8.1 G/L (IQR: 
4-9) vs 6 G/L (IQR: 5-8, P = 0.554); MCV: 88 fl 
(IQR: 88-92) vs 89 fl (IQR: 86-92, P = 0.851); RDW: 
14% (IQR: 13-15) vs 14% (IQR: 13-15, P = 0.979); 
thrombocytes: 249 G/L (IQR: 192-266) vs 244 G/L 
(IQR: 215-302, P = 0.627); CRP: 18 mg/L (IQR: 8-41) 
vs 4 mg/L (IQR: 2-26, P = 0.118); albumin: 36 g/L 
(IQR: 33-42) vs 43 g/L (IQR: 41-45, P = 0.005) (Figure 
1). The area under the ROC curve for preoperative 
albumin predicting recurrence (Figure 2) was 0.840 
(95%CI: 0.642-1, P = 0.002). The cut-off albumin 
level for a sensitivity of 94.5%, a specificity of 75%, a 
positive predictive value of 60%, a negative predictive 
value of 96% and a likelihood ratio of 3.7 was 37.5 g/L. 
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Figure 1  Box-and-whisker plot of preoperative serum albumin level in 
patients with and without alveolar echinococcosis recurrence (P = 0.005).
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CD44 proteins in AE resected liver was associated 
with the development of AE metastasis; however, in 
the multivariate analysis, a low level of CD44 proteins 
did not correlate with OS. The level of CD44 proteins 
in a pathological specimen is not easily assessed, 
and immunohistochemical staining of a resected liver 
sample is necessary. On the contrary, serum albumin 
can be determined easily in the preoperative period. 
Moreover, as a preoperative test, serum albumin can 
provide important information regarding management 
and follow-up. Indeed, in the case of preoperative 
hypoalbuminemia, follow-up can be adapted and 
tailored (e.g., closer follow-up visits with serologies or 
regular postoperative imaging examinations) since the 
patient will be at higher risk for recurrence.
Recently, albumin has been shown to be linked 
to peri-operative stress[9]. Several studies of liver 
surgery and other major surgeries have shown that 
a drop in albumin level correlates with postoperative 
complications[10]. Moreover, preoperative serum albumin 
level has been characterized as an independent 
factor of recurrence and OS after resection of hepato-
cellular carcinoma[16] and of OS in patients with hilar 
cholangiocarcinoma[17]. The tumor-like behavior of AE 
Recurrence-free survival was better for patients with 
preoperative serum albumin level > 37.5 g/L (log-rank 
test: P = 0.0004; Figure 3).
Multivariate analysis
Table 1 summarizes the univariate and multivariate 
Cox regressions for the preoperative values, surgical 
resection margins, lesion size and portal vein invasion. 
Only serum albumin level and surgical resection margins 
showed significance in the univariate analysis (HR = 
0.078, P = 0.003 and HR = 0.137, P = 0.018); these 
two variables retained significance in the multivariate 
analysis (Table 1). The disease-free survival of patients 
according to the different included peri-operative items 
is presented in Table 2.
DISCUSSION
The results of this study suggest that preoperative 
serum albumin level has a good discriminative power 
to predict recurrence in patients operated for liver AE. 
No predictive markers of recurrence after hepatectomy 
for AE have been reported in the literature to date. 
The present study identified low preoperative serum 
albumin as associated with AE recurrence. A recent 
study by Wang et al[15] showed that a low level of 
Table 1 Univariate and multivariate analyses of potential risk factors for alveolar echinococcosis recurrence (Cox regressions)
Univariate Multivariate
HR 95%CI P  value HR 95%CI P  value
Leukocytes > 9 g/L 1.572   0.171-14.454 0.690
MCV > 90 fl 0.298 0.034-2.647 0.278
RDW > 14 % 0.444 0.080-2.461 0.353
Thrombocytes > 300 g/L 0.044   0.001-68’792 0.692
CRP > 20 mg/mL 1.061 0.171-6.567 0.949
Hemoglobin > 130 g/L 0.789 0.132-4.738 0.796
Bilirubin > 10 µmol/L 0.242 0.040-1.472 0.124
Albumin > 37.5 g/L 0.078 0.015-0.415 0.003 0.099 0.018-0.530 0.007
R0 resection 0.137 0.027-0.711 0.018 0.182 0.034-0.962 0.045
Lesion size > 5 cm 3.342   0.385-28.998 0.274
PV invasion1 3.564   0.769-16.511 0.104
1Defined as presence of microscopic invasion of the PV by alveolar echinococcosis on histopathological reports. CRP: C-reactive protein; MCV: Mean 
corpuscular volume; PV: Portal vein; RDW: Red blood cell distribution width.
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Figure 2  Receiver operating characteristic curve for preoperative serum 
albumin level to predict recurrence of alveolar echinococcosis (AUC = 
0.840, 95%CI: 0.642-1, P = 0.002).
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Figure 3  Kaplan-Meier curves of recurrence-free survival (log-rank test: P 
= 0.0004). Alb: Albumin.
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is probably more similar to a cancer such as cholan-
giocarcinoma than to those cancers frequently related 
to underlying liver diseases, such as hepatocellular 
carcinoma which commonly presents with hepatitis 
and/or cirrhosis. 
The findings of the present study suggest that the 
inflammatory state that accompanies AE likely plays a 
role in the production of albumin in the liver. It can be 
postulated that the hepatic parasitic load of Echinococcus 
multilocularis disturbs the standard albumin production 
by the hepatocytes. Therefore, albumin level could 
predict the risk of AE recurrence as a reflection of the 
inflammatory state of the liver. Moreover, intrahepatic 
dissemination of the parasites could decrease albumin 
synthesis, but these explanations are speculative. The 
underlying pathological mechanisms still need to be 
investigated. In the present study’s cohort, no patient 
received intravenous albumin supplementation, even 
in cases of preoperative hypoalbuminemia. If surgeons 
routinely use albumin supplementation preoperatively, 
it can be suggested that the albumin level that would 
correlate to the recurrence risk would be the serum 
albumin level before supplementation. As no data exist 
on albumin supplementation and AE, further studies 
need to be performed to clarify the role of albumin 
supplementation preoperatively for patients with AE.
A surgical resection with positive histological margins 
was also identified as an independent risk factor 
for AE recurrence in the present study. This finding 
confirms the importance of a complete resection of 
the parasitic lesion in order to reduce the risk of re-
currence. Although, the best distance for achieving a 
safe surgical resection margin is not clearly established 
and remains controversial. The WHO expert consensus 
has recommended a margin of 2 cm[12]. A previous 
paper from our group showed that the margin distance 
recommended for hepatocellular carcinoma (i.e., 1 mm) 
reached the same long-term postoperative outcomes[3]. 
The resection surgical margin distance needs to be 
further studied to confirm the safety of a margin defined 
as < 2 cm.
The present study has several limitations that must 
be addressed. First, its retrospective nature has inherent 
biases related to chart review and missing data. 
Second, the number of patients was relatively small. 
However, the rarity of the disease and the low incidence 
of recurrence have to be taken into consideration. The 
patient cohort involved in the present study represents 
one of the largest series of patients operated for AE in 
the literature. Finally, the long study period can induce 
a historical bias due to improvement of experience and 
expertise of the team over the years. 
In conclusion, low preoperative serum albumin may 
be a predictive factor for AE recurrence after primary 
hepatectomy. This easily obtainable blood marker 
could help in guiding postoperative follow-up of AE 
patients and should be a recommended preoperative 
test.
COMMENTS
Background
Alveolar echinococcosis (AE) is a rare parasitic infection, primarily involving 
the liver. As AE behaves like a malignant tumor (liver parenchyma invasion), 
surgical resection is the treatment of choice to remove all lesions. The recurrence 
rate after surgical resection is around 5%. No predictive blood markers for AE 
recurrence after hepatectomy have been described in the literature to date. 
Research frontiers
New studies on AE have aimed to describe tailoring of the features of 
postoperative follow-up for AE patients [e.g., length of albendazole treatment, 
feasibility of positron emission tomography-computed tomography (PET-CT) 
scan, or predictive markers of recurrence]. 
Innovations and breakthroughs
Recent articles on AE have evaluated the feasibility of postoperative PET-CT 
scan for the follow-up of operated AE patients. No preoperative markers of AE 
recurrence have yet been described in the literature.  
Applications
The results of this study can be used in daily clinical practice. Indeed, dosing of 
preoperative serum albumin level in patients with liver AE could help in guiding 
the postoperative follow-up since patients with low albumin level are at higher 
risk for AE recurrence.
Terminology
AE is a parasitic infection that can disseminate within the liver or give rise to 
distant extrahepatic lesions. Echinococcus multilocularis is the parasitic agent 
causing AE.
Peer-review
This is a single-center retrospective study of 68 patients who underwent 
liver resection for AE. The authors found that preoperative albumin level is a 
Table 2  Disease-free survival of patients according to various 
peri-operative criteria
Median DFS, mo (IQR) P  value
Leukocytes > 9 g/L 65 (6-81) 0.545
Leukocytes ≤ 9 g/L     58 (23-107)
MCV > 90 fl     69 (29-121) 0.116
MCV ≤ 90 fl   58 (15-92)
RDW > 14%     68 (28-117) 0.154
RDW ≤ 14% 56 (8-81)
Thrombocytes > 300 g/L     68 (30-128) 0.510
Thrombocytes ≤ 300 g/L     58 (18-102)
CRP > 20 mg/mL     68 (13-105) 0.325
CRP ≤ 20 mg/mL 50 (9-74)
Hemoglobin > 130 g/L     65 (25-111) 0.440
Hemoglobin ≤ 130 g/L     41 (13-107)
Bilirubin > 10 µmol/L     60 (12-129) 0.488
Bilirubin ≤ 10 µmol/L   44 (25-81)
Albumin > 37.5 g/L   56 (26-79) 0.048
Albumin ≤ 37.5 g/L   25 (13-57)
R0 resection     69 (27-129) 0.024
R1 resection   41 (12-92)
Lesion size > 5 cm   65 (8-102) 0.733
Lesion size ≤ 5 cm     50 (25-114)
PV invasion1   56 (7-130) 0.933
No PV invasion     60 (25-105)
1Defined as presence of microscopic invasion of the PV by alveolar 
echinococcosis on histopathological reports. CRP: C-reactive protein; DFS: 
Disease-free survival; IQR: Interquartile range; MCV: Mean corpuscular 
volume; PV: Portal vein; RDW: Red blood cell distribution width. 
 COMMENTS
Joliat GR et al . Hypoalbuminemia and recurrent alveolar echinococcosis
858 February 7, 2017|Volume 23|Issue 5|WJG|www.wjgnet.com
significant risk factor for recurrence of AE. This is an interesting result from a 
highly experienced European center for AE.
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